The possibility of using magnetic nanoparticles to increase the therapeutic efficiency of Herceptin antibody
- 1 January 2015
- journal article
- research article
- Published by Walter de Gruyter GmbH in Biomedical Engineering / Biomedizinische Technik
- Vol. 60 (5) , 485-490
Abstract
Introduction: Herceptin is an expensive humanized antibody used for the treatment of early-stage breast cancers. This antibody can cause cardiotoxicity in some patients. In this study, we evaluated the possibility of increasing the therapeutic efficacy of Herceptin by combining magnetic nanoparticles and a permanent magnet for more accumulation in the tumor site.Methods: Herceptin magnetic nanoparticles (HMNs) were synthesized and some of their characteristics, such as stability, magnetization, particle size by transmission electron microscopy (TEM), and dynamic light scattering (DLS) technique, were measured. The biodistribution study was checked in mice bearing breast tumor with and without a permanent magnet on the position of the tumor. The therapeutic effects of HMNs were considered in this condition.Results: The size distribution of HMNs determined by the DLS technique was 182±7 nm and the average size by TEM was 100±10 nm. The reductions of 81% and 98% in the mean tumor volume for the group that received HMNs with magnetic field were observed at 42 and 45 days after injection, respectively.Conclusion: The good results in mice indicated that Herceptin-loaded iron oxide nanoparticles with external magnetic field have good potential for use in humans as a targeted drug delivery that needs more investigation.Keywords
This publication has 18 references indexed in Scilit:
- Effect of adjuvant/neoadjuvant trastuzumab on clinical outcomes in patients with HER2‐positive metastatic breast cancerCancer, 2014
- Superparamagnetic iron oxide nanoparticles mediated 131I-hVEGF siRNA inhibits hepatocellular carcinoma tumor growth in nude miceBMC Cancer, 2014
- Nanoparticles for cancer imaging: The good, the bad, and the promiseNano Today, 2013
- Characterization of magnetic nanoparticle systems with respect to their magnetic particle imaging performanceBiomedical Engineering / Biomedizinische Technik, 2013
- Magnetic Particle Imaging – from particle science to imaging technologyBiomedical Engineering / Biomedizinische Technik, 2013
- Magnetic nanoparticles and targeted drug deliveringPharmacological Research, 2010
- MRI contrast agent for molecular imaging of the HER2/neu receptor using targeted magnetic nanoparticlesJournal of Nanoparticle Research, 2010
- A History of Cancer ChemotherapyCancer Research, 2008
- MR imaging of the her2/neu and 9.2.27 tumor antigens using immunospecific contrast agentsMagnetic Resonance Imaging, 2004
- Determination of the immunoreactive function of radiolabeled monoclonal antibodies by linear extrapolation to binding at infinite antigen excessJournal of Immunological Methods, 1984